Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
---|
01/21/2004 | EP0811002B1 Benzylpiperidines and piperazines as muscarinic antagonists |
01/21/2004 | CN1469866A New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication |
01/21/2004 | CN1469862A 2,2-diphenyl butanamide derivatives and medicines containing the same |
01/21/2004 | CN1469860A Aza-amino acid derivatives (factor XA-inhibitors 15) |
01/21/2004 | CN1135229C Water soluble azoles as broad-spectrum antifungals |
01/20/2004 | US6680321 4-((1-piperazinylmethyl)-benzamide derivatives; hypotensive agents; immunomodulators |
01/20/2004 | US6680320 Urokinase inhibitors |
01/20/2004 | US6680317 N-(phenyl)-n*-(2-hydroxy-3-aminosulfonylphenyl)guanidine derivatives; chemokine inhibitors; respiratory, cardiovascular, rheumatic, brain, and nervous system disorders |
01/20/2004 | CA2243404C Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
01/17/2004 | CA2435399A1 New anthracene derivatives and their use as pharmaceutical preparations |
01/15/2004 | WO2004005513A2 Methods for specifically inhibiting histone deacetylase-7 and 8 |
01/15/2004 | WO2004005278A1 Bisarylsulfonamide compounds and their use in cancer therapy |
01/15/2004 | WO2004005229A1 Modulators of the glucocorticoid receptor |
01/15/2004 | WO2004004648A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
01/15/2004 | WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
01/15/2004 | US20040010149 Ligand for transition metal complex catalyst |
01/15/2004 | US20040010106 Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom |
01/15/2004 | US20040010037 Cyanophenyl derivative |
01/15/2004 | US20040009994 Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions |
01/15/2004 | US20040009987 4-phenylpiperidinyl- or 4-phenylpiperazinyl-; including N-oxides |
01/15/2004 | US20040009985 Bicyclo 4.4.0 antiviral derivatives |
01/15/2004 | US20040009982 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |
01/15/2004 | US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity |
01/15/2004 | US20040009923 Alpha-substituted methyl ketones derived from aspartic acid and the closed hemi-ketal forms thereof |
01/15/2004 | CA2491994A1 Modulators of the glucocorticoid receptor |
01/15/2004 | CA2491127A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
01/15/2004 | CA2490579A1 Methods for specifically inhibiting histone deacetylase-7 and 8 |
01/15/2004 | CA2488816A1 Bisarylsulfonamide compounds and their use in cancer therapy |
01/14/2004 | EP1380569A1 Ionic liquid, electrolyte salt for storage device, electrolytic solution for storage device, electric double layer capacitor, and secondary battery |
01/14/2004 | EP1380562A1 Carboxylic acid derivative and salt thereof |
01/14/2004 | EP1380306A1 Remedies for psychoneurosis |
01/14/2004 | EP1379515A1 Lipid lowering biphenylcarboxamides |
01/14/2004 | EP1379509A1 A method for the preparation of oxazolidinones |
01/14/2004 | EP1379498A1 Sulphones which modulate the action of gamma secretase |
01/14/2004 | EP1379496A1 Sulphones which modulate the action of gamma secretase |
01/14/2004 | EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
01/14/2004 | EP1379234A1 Halogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf |
01/14/2004 | EP1212292B1 (-)-verbenone derivatives |
01/14/2004 | EP1147098B1 Compounds comprising acrylate and cyclic sec.-amine functionalities |
01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
01/14/2004 | CN1468207A New retinoids for the treatment of emphysema |
01/14/2004 | CN1468113A Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
01/14/2004 | CN1134457C New alpha-aminoacetophenone photoinitiators |
01/14/2004 | CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists |
01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
01/14/2004 | CN1134410C Amine derivative, process for producing same, and use thereof as antiarrhythmic medicine |
01/13/2004 | US6677486 Hydrogenating nitrites to primary amines over an activated, alpha-aluminum oxide(al2o3)-containing, macroporous raney catalyst based on an alloy of aluminum and at least one transition metal |
01/13/2004 | US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents |
01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
01/13/2004 | US6677378 Monoamine reuptake inhibitors for treatment of CNS disorders |
01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
01/13/2004 | US6677367 Lysine derivative with 2-aminosulfonylthiophene substituent; acquired immunodeficiency syndrome (aids) viricides |
01/13/2004 | US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
01/13/2004 | US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
01/13/2004 | US6677343 Substituted piperazine compounds |
01/13/2004 | US6677336 Substituted piperazine compounds |
01/13/2004 | US6677308 Integrin antagonists; antitumor, antimetastasis, anticarcinogenic agents; angiogenesis and restenosis inhibitors; osteoporosis |
01/13/2004 | US6676928 Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use |
01/13/2004 | US6676926 Radiopharmaceuticals for diagnosing Alzheimer's disease |
01/08/2004 | WO2004002965A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
01/08/2004 | WO2004002944A1 Inhibitors of hcv ns5b polymerase |
01/08/2004 | WO2004002940A1 Inhibitors of hcv ns5b polymerase |
01/08/2004 | WO2004002939A2 Aminoalcohol derivatives |
01/08/2004 | WO2004002491A1 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
01/08/2004 | WO2003064378A3 Novel compounds that inhibit factor xa activity |
01/08/2004 | WO2003047515A3 P2x7 receptor antagonists |
01/08/2004 | US20040006238 As chemical intermediates for production of pharmacologically useful oxazolidinones |
01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
01/08/2004 | US20040006143 Aminoalcohol derivatives |
01/08/2004 | US20040006141 Amidocarboxylic acid compounds |
01/08/2004 | US20040006134 Antiandrogenic biphenyls |
01/08/2004 | US20040006080 Chemical compounds |
01/08/2004 | US20040006061 Suitable for the antimicrobial treatment of surfaces, as antimicrobial active substances against gram-positive and gram-negative bacteria |
01/08/2004 | US20040006049 For therapy of prostatitis, benign prostate hyperplasia or prostate cancer |
01/08/2004 | CA2492065A1 Aminoalcohol derivatives_as b3 adrenergic receptor agonist |
01/08/2004 | CA2491156A1 Inhibitors of hcv ns5b polymerase |
01/08/2004 | CA2490950A1 Inhibitors of hcv ns5b polymerase |
01/08/2004 | CA2488525A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
01/07/2004 | EP1378230A1 Para-phenylenediamine derivatives comprising a pyrrolidinyl group substituted by a cyclic radical and their use in colouring keratinic fibres |
01/07/2004 | EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
01/07/2004 | EP1377571A1 Compounds for use in the treatment of skin conditions |
01/07/2004 | EP1377542A1 Hiv protease inhibitors based on amino acid derivatives |
01/07/2004 | EP1377536A1 Self-reducing anthraquinone compounds |
01/07/2004 | EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
01/07/2004 | EP1377282A2 Aryl-n-cyanoguanidines and methods related thereto |
01/07/2004 | EP1056733B1 Histamine h3 receptor ligands |
01/07/2004 | EP0944611B1 Dimesylate salts of neuropeptide y ligands |
01/07/2004 | CN1466569A Novel 3-substituted urea derivatives and medicinal use thereof |
01/07/2004 | CN1133618C Method for prodn. of amino ethyl-hydramine and/or ethylol piperazine |
01/06/2004 | US6673850 Odorless photoinitiator compounds having chain transfer groups |
01/06/2004 | US6673799 Inhibits binding to androgen receptor; antiandrogen |
01/06/2004 | CA2253870C Inhibition of matrix metalloproteases by substituted phenalkyl compounds |
01/06/2004 | CA2145248C Pharmaceutical compositions containing time-released orally taken trimetazidine |
01/02/2004 | EP1375476A1 A new process for the synthesis of alkoxyamines active in controlled radical polymerization |
01/02/2004 | EP1375457A1 One-pot process for the preparation of functionalized alkoxyamines |
01/02/2004 | EP1374868A1 Remedies and/or preventives for diabetic ischemic heart diseases |
01/02/2004 | EP1373234A2 Urokinase inhibitors |